Clinical Trial

Genome Analysis Across Populations in Inflammatory Bowel Disease

Name: Genome Analysis Across Populations in Inflammatory Bowel Disease — clinical trial record (NCT06042387)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-09-13.

Trial Details

NCT Number	NCT06042387
Lead Sponsor	Mount Sinai Hospital, Canada Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Ulcerative Colitis, Healthy, Crohn Disease, Inflammatory Bowel Diseases
Enrollment	150 participants
Start Date	2022-05-01
Primary Completion	2027-05 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-03-25